인대 강화 치료
The optimal long-term, symptomatic therapy for chronic shoulder pain has not been established. Accordingly,
we investigated the outcomes of patients undergoing Hackett-Hemwall dextrose Prolotherapy treatment for unresolved shoulder pain at a charity clinic in rural Illinois.
We studied a sample of 94 patients with an average of 53 months of unresolved shoulder pain that were treated quarterly with Prolotherapy. An average of 20 months following their last Prolotherapy session, patients were contacted and asked numerous questions in regard to their levels of pain and a variety of physical and psychological symptoms, as well as activities of daily living, before and after their last Prolotherapy treatment.
The results of this study showed that patients had a statistically significant decline in their level of pain, stiffness, and crunching sensations (crepitation), to the p<.0000001 level with Prolotherapy, including the 39% of patients who were told by their medical doctors that there were no other treatment options for their pain and the twenty-one percent who were
told that surgery was their only option.
Over 82% of all patients experienced improvements in sleep, exercise ability, anxiety, depression, and overall disability with Prolotherapy. Ninety-seven percent of patients received pain relief with Prolotherapy. Conclusion: In this study,
patients with chronic shoulder pain reported significant
improvements in many clinically relevant parameters
and overall quality of life after receiving Hackett-Hemwall
dextrose Prolotherapy.
Journal of Prolotherapy. 2009;4:205-216
프롤로 논문.pdf